Analysis from Public Health England (PHE) published on Monday shows that the vaccine manufactured by Pfizer-BioNTech reduces the risk of catching infection by more than 70 percent after the first dose. That risk is reduced by 85 percent after a second dose.
“Overall, we’re seeing a really strong effect to reducing any infection, asymptomatic and symptomatic,” PHE’s strategic response director Susan Hopkins told a media briefing.
In a statement posted on social media, Matt Hancock, the secretary of state for Health & Social Care, welcomed the development as “incredibly good news”.
“It shows that the vaccines work and it shows that vaccines save lives.”
The public health body’s study of real-world data also shows those vaccinated people who do become infected are far less likely to die or be hospitalised.
Hospitalisation and death from the virus is reduced by more than 75 percent in those who have received a dose of the Pfizer-BioNTech vaccine, according to the analysis.
No comments :
Post a Comment
Only News